For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…
Read More
NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus
The National Institutes of Health (NIH) has released a groundbreaking study detailing the complex intracellular signaling processes triggered by GLP-1…
Read More
The $1.8 Billion Telehealth Conundrum: Medvi’s Rise Amidst Regulatory Gaps, AI Deception, and the Compounded Drug Market
A recent profile by The New York Times celebrated Medvi, a burgeoning telehealth enterprise, as a testament to the transformative…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Innovative Bone Marrow-on-a-Chip Platform Developed by Penn and CHOP Researchers to Revolutionize Drug Testing and Aerospace Medicine
Deep within the skeletal framework of the human body lies a complex, high-performance factory: the bone marrow. This sponge-like tissue…
Read More
Recent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery Hopes
In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…
Read More
Popular Anti-Aging Drug Combination Linked to Significant Brain Damage and Myelin Loss in New Study
A drug combination that has become a cornerstone of modern longevity research may carry unforeseen and devastating consequences for neurological…
Read More
A Novel Drug Screening Platform Revolutionizes Approach to Neurological and Psychiatric Disorders by Targeting Protein Expression Imbalances
Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation
On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…
Read More
